Artificial Intelligence in Drug Discovery and Development Nptel Week 2 Answers

Are you looking for AI in Drug Discovery and Development Week 2 Answers ? All weeks solutions of this swayam course assignment are available here.


AI in Drug Discovery and Development Week 2 Answers
AI in Drug Discovery and Development Week 2 Answers

AI in Drug Discovery and Development Week 2 Answers (July-Dec 2025)

Course link: Click here to visit course on Nptel Website


Question 1. What is the average cost of bringing a single drug to market through traditional discovery methods?
a) $500 million
b) $1.2 billion
c) $2.6 billion
d) $10 billion

View Answers


Question 2. What does SAR stand for in hit-to-lead optimization?
a) Standardized Affinity Ratio
b) Structure-Activity Relationship
c) Signal Activity Response
d) Synthesis and Reactivity

View Answers


Question 3. Which platform is known for integrating CRISPR knockout data with AI for target validation?
a) CanSAR
b) DepMap
c) OpenTargets
d) Cell Painting

View Answers


Question 4. What kind of toxicity is predicted using hERG channel models in AI safety pharmacology?
a) Nephrotoxicity
b) Cardiotoxicity
c) Hepatotoxicity
d) Neurotoxicity

View Answers


Question 5. Which tool supports automated regulatory documentation for IND submission?
a) SmartSolve
b) RegDocs365
c) GastroPlus
d) Trial Pathfinder

View Answers

These are AI in Drug Discovery and Development Week 2 Answers


Question 6. Which AI platform helped optimize a cancer lead series EXS21546?
a) Exscientia
b) GNS Healthcare
c) Healx
d) IQVIA

View Answers


Question 7. What does ADMET stand for?
a) Advanced Dose Modeling and Experimental Toxicology
b) Absorption, Distribution, Metabolism, Excretion, and Toxicity
c) Artificial Design Metrics Evaluation Tool
d) Analytical Drug Manufacturing Evaluation Technique

View Answers


Question 8. Which AI tool was used to simulate human PK/PD profiles for dose decisions?
a) REINVENT
b) Formulation.ai
c) GastroPlus
d) Cell Painting

View Answers


Question 9. Which platform created virtual patient cohorts to simulate responses across demographics?
a) Phesi
b) Deep6 AI
c) Trial Pathfinder
d) GNS Healthcare

View Answers


Question 10. Which AI-powered pharmacovigilance system analyzes EHRs and social media?
a) Aetion
b) Flatiron Health
c) Saama
d) Medidata AI

View Answers

These are AI in Drug Discovery and Development Week 2 Answers


Question 11. Which step in drug discovery directly benefits from protein structure prediction by AI?
a) ADMET
b) Target Identification
c) Hit-to-Lead
d) Patient Recruitment

View Answers


Question 12. Why does AI improve success rates in drug development?
a) It reduces the number of animal studies.
b) It ensures lower manufacturing costs.
c) It enables earlier and more accurate identification of failures.
d) It increases patient compliance.

View Answers


Question 13. How does AI help in reducing clinical trial failures?
a) By improving packaging and distribution
b) By predicting success rates based on previous trials and stratifying patients
c) By automating marketing approvals
d) By outsourcing recruitment

View Answers


Question 14. What is the biggest advantage of virtual screening powered by AI in hit identification?
a) Cost of reagents is eliminated
b) Clinical trials can be skipped
c) It enables rapid screening of millions of compounds
d) It guarantees FDA approval

View Answers


Question 15. Ethical concerns in AI-driven drug discovery primarily relate to:
a) Lack of medicinal chemistry expertise
b) Data privacy and model transparency
c) Shortage of patients
d) Clinical trial dropout rates

View Answers


These are AI in Drug Discovery and Development Week 2 Answers

Click here for all nptel assignment answers